Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Urs Michael Weber

TitleAssistant Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Waliany S, Cooper AJ, Liu SV, Gautschi O, Rotow JK, Smith KER, Weber UM, Lee DH, Loong HHF, Patel JD, Pennell NA, Nagasaka M, Patel SA, Tan DSW, Solomon BJ, Kim TM, Pall G, Riess JW, Sun L, Früh M, Uy NF, Gadgeel S, Feng J, Do A, Falcon C, Leighl NB, Baik CS, Lai GGY, Ou SI, Cheung KSY, Patil T, Mansfield AS, Weiler D, Yeap BY, Wirth LJ, Gainor JF, Drilon A, Lin JJ. Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium. Clin Cancer Res. 2026 Mar 16; 32(6):1157-1168. PMID: 41537704.
      View in: PubMed
    2. Waliany S, Roy SG, Pecci F, Weber UM, Sun F, Arter Z, Lomibao M, Alessi JV, Nishino M, Luo F, Repetto M, Falcon C, Do A, Peterson J, Liang J, Liu A, Nagasaka M, Ricciuti B, Drilon A, Ou SI, Neal JW, Patil T, Awad M, Yeap BY, Digumarthy SR, Lin JJ. Efficacy and Safety of Continuing Next-Generation ALK TKIs With Chemotherapy for Advanced ALK-Positive NSCLC: A Multicenter Retrospective Study. J Natl Compr Canc Netw. 2025 Nov 19; 23(12):522-530. PMID: 41671458.
      View in: PubMed
    3. Weber UM, Bailis JM, Coxon A, Pine SR, Giaccone G. Editorial: Advancements in drug development: exploring bi-specific antibodies as promising therapeutic strategies in oncology. Front Oncol. 2025; 15:1651944. PMID: 40697387.
      View in: PubMed
    4. Weber UM, Watson AS, Kavanagh BD, Bunn PA. Accelerated hypofractionated chemoradiation followed by stereotactic ablative radiotherapy boost for locally advanced, unresectable non-small cell lung cancer. Transl Cancer Res. 2025 Feb 28; 14(2):676-678. PMID: 40104723.
      View in: PubMed
    5. Weber UM, Einhorn L, Bunn PA. ALK-Rearranged Non-Small Cell Lung Cancer Presenting as a Large Mediastinal Mass: A Case Report. JCO Precis Oncol. 2025 Feb; 9:e2400536. PMID: 39938009.
      View in: PubMed
    6. Weber U, Davies KD, Camidge DR. L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrectinib Responds to Cabozantinib: A Case Report. JTO Clin Res Rep. 2024 Jul; 5(7):100673. PMID: 39091594.
      View in: PubMed
    7. Morris JC, Gould Rothberg BE, Prsic E, Parker NA, Weber UM, Gombos EA, Kottarathara MJ, Billingsley K, Adelson KB. Outcomes on an inpatient oncology service after the introduction of hospitalist comanagement. J Hosp Med. 2023 05; 18(5):391-397. PMID: 36891947.
      View in: PubMed
    Weber's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)